Cellectar Biosciences, Inc. Business Finance Contracts & Agreements
87 Contracts & Agreements
- Debenture Agreements (1 contract)
- Equity Distribution Agreements (1)
- Exchange Agreements (3)
- Loan Agreements (1)
- Note Agreements (2)
- Purchase Agreements (12)
- Registration Rights Agreements (8)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (17)
- Underwriting Agreements (7)
- Waiver Agreements (1)
- Warrant Agreements (32)
- Form of Securities Purchase Agreement, dated September 5, 2023, by and among the Company and the purchasers named therein (Filed With SEC on September 8, 2023)
- Form of Tranche B Warrant (Filed With SEC on September 8, 2023)
- Form of Tranche A Warrant (Filed With SEC on September 8, 2023)
- Form of Registration Rights Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein (Filed With SEC on October 25, 2022)
- Form of PIPE Securities Purchase Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein (Filed With SEC on October 25, 2022)
- Form of Hybrid Securities Purchase Agreement, dated as of October 20, 2022, by and between the Company and the purchasers named therein (Filed With SEC on October 25, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on October 25, 2022)
- Form of Common Warrant (Filed With SEC on October 25, 2022)
- Form of Registration Rights Agreement (Filed With SEC on December 28, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on December 28, 2020)
- Form of Series D Preferred Stock Certificate (Filed With SEC on December 28, 2020)
- Form of Underwriting Agreement (Filed With SEC on December 28, 2020)
- Equity Distribution Agreement between Cellectar Biosciences, Inc. and Oppenheimer & Co. Inc., dated August 11, 2020 (Filed With SEC on August 11, 2020)
- Form of Warrant Agency Agreement (Filed With SEC on June 5, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on May 20, 2020)
- Form of Series H Warrant (Filed With SEC on May 20, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 20, 2020)
- Stock Option Agreement with Igor Grachev (Filed With SEC on March 9, 2020)
- Stock Option Agreement with Dov Elefant (Filed With SEC on March 9, 2020)
- Registration Rights Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers (Filed With SEC on May 20, 2019)
- Private Placement Securities Purchase Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers (Filed With SEC on May 20, 2019)
- Securities Purchase Agreement, dated as of May 16, 2019, by and among Cellectar Biosciences, Inc. and the Purchasers (Filed With SEC on May 20, 2019)
- Form of Series G Common Stock Purchase Warrant (Filed With SEC on May 20, 2019)
- Form of Series F Common Stock Purchase Warrant (Filed With SEC on May 20, 2019)
- Form of Non-Statutory Stock Option (Definitive/Contingent Directors) (Filed With SEC on November 13, 2018)
- Form of Non-Statutory Stock Option (Definitive/Contingent Employees) (Filed With SEC on November 13, 2018)
- Form of Warrant Agency Agreement (Filed With SEC on July 18, 2018)
- Form of Series C Preferred Stock Certificate (Filed With SEC on July 18, 2018)
- Form of Series E Common Stock Purchase Warrant (Filed With SEC on July 18, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 18, 2018)
- Registration Rights Agreement, dated as of October 10, 2017, by and among Cellectar Biosciences, Inc. Inc. and the Purchasers (Filed With SEC on October 11, 2017)
- Securities Purchase Agreement, dated as of October 10, 2017, by and among Cellectar Biosciences, Inc. Inc. and the Purchasers (Filed With SEC on October 11, 2017)
- Form of Series B Preferred Stock certificate (Filed With SEC on October 11, 2017)
- Form of Series D Common Stock Purchase Warrant (Filed With SEC on October 11, 2017)
- Cellectar Biosciences, Inc. AMENDED AND RESTATED 2015 STOCK INCENTIVEPLAN (Filed With SEC on June 1, 2017)
- Cellectar Biosciences, Inc. and American Stock Transfer & Trust Company,LLC, as Warrant Agent (Filed With SEC on November 18, 2016)
- SERIES C-2016 COMMON STOCK PURCHASE WARRANT cellectarbiosciences, inc. (Filed With SEC on November 18, 2016)
- _________ SHARESof Common StOCK _________ SHARESOF SERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO______ SHARES OF COMMON STOCK) and __________SERIES C WARRANTS... (Filed With SEC on November 18, 2016)
- Cellectar Biosciences, Inc. and American Stock Transfer & Trust Company,LLC, as Warrant Agent (Filed With SEC on April 14, 2016)
- SERIES B-2016 PRE-FUNDED COMMON STOCKPURCHASE WARRANT cellectarbiosciences, inc. (Filed With SEC on April 14, 2016)
